Evidence map›Paper›PMID 41410884›Full record

ArticleRevista colombiana de obstetricia y ginecologia2025

Prevalence and characterization of the use of erotic toys in Colombian women

Franklin José Espitia De La Hoz

Abstract readMulticenter StudyEnglish Abstract
In one paragraph

Article in Revista colombiana de obstetricia y ginecologia, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Franklin José Espitia De La HozDepartamento de Uroginecología y Cirugía reconstructiva del piso pélvico, Urogolyn Care. (Armenia, Colombia).ORCID 0000-0002-4581-9680

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To describe the prevalence of sex toy use in women, characterize the most commonly used devices, and their effect on the Female Sexual Function Index (FSFI) score. Material and methods: Multicenter crosssectional study. Women over 18 years of age with a stable partner, residing in Colombia, were included. Participants were recruited from the gynecological outpatient clinics of high-complexity private clinics in 21 cities across the country between 2019 and 2024. A sample size calculation was performed, and simple random sampling was used. The IFSF was applied. Socio-demographic characteristics, sexual orientation, use of sex toys, type of device used, individual or partner use, overall and domainspecific Female Sexual Function Index (FSFI) score, were measured. A descriptive analysis was performed. Results: A total of 1,759 women were included, of whom 1,280 used sex toys, for a prevalence of use of 72.76%. Homosexual women used toys more frequently than heterosexual women. The mean IFSF score for sex toy users was 29.55 (standard deviation (SD) ± 9.12) and for non-users it was 27.43 (SD ± 8.59); (p = 0.027). The highest-scoring domain was orgasm (4.97 ± 1.29), followed by desire (4.95 ± 1.68), (p = 0,027). The most frequently used toys were the dilido (53.49%) and the vibrator (48.15%). Conclusions: The use of sex toys among Colombian women is a common practice, so their use should be investigated during gynecological consultations. Studies are needed to evaluate the sexual and reproductive health of women who use sex toys.

Indexed as

EroticaSexual BehaviorAdolescentAdultColombiaCross-Sectional StudiesFemaleHomosexuality, FemaleHumansMiddle AgedOrgasmPrevalenceYoung AdultPlay and playthingsPrevalenceSexualitySexual partnersTherapeutic usesWomen

Identifiers

PMID41410884
PMCPMC12649782

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.